TCTR20201008001已完成未知
Three year randomized clinical trial to evaluate the clinical performance of glass ionomer restorative systems in class I and II cavities
none0 个研究点目标入组 40 人开始时间: 2020年10月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 40 Years（—）
- 性别
- All
入选标准
- •(1) a need for at least four posterior tooth-colored restorations in permanent premolars and molars, (2) small to medium sized primary carious lesions Class I or II, (3) the presence of teeth to be restored in contact with the adjacent teeth and in normal occlusion with the natural antagonist teeth, (4) symptomless vital teeth with
排除标准
- •1) spontaneous pain or sensitivity to percussion, (2) partly erupted or endodontic treated teeth, (3) poor oral hygiene or severe periodontitis, (4) absence of neighboring or antagonist teeth, (5) adverse medical history, allergies or systemic diseases
研究者
相似试验
尚未招募
3 期
CARG risk score based chemotherapy in older patients with advanced GI cancers phase III trialCTRI/2022/03/040884Tata Memorial Hospital
已完成
3 期
Clinical trial, phase 3, to evaluate the efficacy of CVO + for the treatment of COVID-19.COVID-19PACTR202103601407640PHARAMALAGASY338
进行中（未招募）
1 期
A Randomized Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Treatment with OncoVEX GM-CSF Compared to Subcutaneously Administered GM-CSF in Melanoma Patients with Unresectable Stage IIIb, IIIc and IV Diseasenresectable Stage IIIb, IIIc and IV MelanomaEUCTR2008-006140-20-GBBioVex Inc437
进行中（未招募）
不适用
A phase III, open, randomized, trial to evaluate the immunogenicity and safety of a single or two-dose schedule of the A/California/7/2009 (H1N1)v-like candidate vaccine manufactured in Dresden adjuvanted with AS03A, in adults aged 18 years and above - FLU D-PAN H1N1-008Immunization against A/California/7/2009 (H1N1)v-like influenza in male and female subjects aged 18 years and above.EUCTR2009-013837-92-BEGlaxoSmithKline Biologicals240
进行中（未招募）
1 期
A study to evaluate if the use of the patients own stem cells in combination with a biomaterial is as good as the standard treatment, bone transplantation.Patients in need of dental implant(s) in the upper and lower jaws with presence of bone defects with loss in vertical height and < than 4 mm in lateral widthMedDRA version: 21.0Level: LLTClassification code 10005958Term: Bone disorder NOSSystem Organ Class: 100000004859EUCTR2018-001227-39-DKniversity of Bergen, Faculty of Medicin, Department of Clinical Dentistry150